Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MacroGenics Inc (NASDAQ:MGNX)

20.52
Delayed Data
As of Feb 21
 -0.87 / -4.07%
Today’s Change
14.85
Today|||52-Week Range
33.30
+0.39%
Year-to-Date

Today’s Trading

Previous close21.39
Today’s open21.49
Day’s range20.38 - 21.49
Volume143,647
Average volume (3 months)277,045
Market cap$745.1M
Dividend yield--
Data as of 4:00pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)+55.00%
Earnings growth (this year)-137.87%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.00%
P/E ratioNM
Price/Sales9.77
Price/Book2.34

Competitors

 Today’s
change
Today’s
% change
PGNXProgenics Pharmaceut...-0.18-1.69%
HRTXHeron Therapeutics I...-0.20-1.40%
ACRSAclaris Therapeutics...-0.23-0.82%
AKAOAchaogen Inc-0.13-0.57%
Data as of 4:00pm ET, 02/21/2017

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)-$0.88
Annual revenue (last year)$100.9M
Annual profit (last year)-$20.1M
Net profit margin-19.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott E. Koenig
Chief Financial Officer, Secretary &
VP
James Karrels
Corporate headquarters
Rockville, Maryland

Forecasts


Search for Jobs